Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

<p>Abstract</p> <p>Background</p> <p>ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies. Although specific ErbB2-targeted therapies have been designed, only a small percentage of patients respon...

Full description

Bibliographic Details
Main Authors: Flores Juana M, Moreno-Bueno Gema, Cerutti Camilla, Pérez-Gómez Eduardo, Mira Emilia, Andradas Clara, Caffarel María M, García-Real Isabel, Palacios José, Mañes Santos, Guzmán Manuel, Sánchez Cristina
Format: Article
Language:English
Published: BMC 2010-07-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/9/1/196

Internet

http://www.molecular-cancer.com/content/9/1/196

Similar Items